Risk Factors for Severe Outcomes in Patients With Systemic Vasculitis and COVID-19: A Binational, Registry-Based Cohort Study. (2021)

First Author: Rutherford MA
Attributed to:  MICA: Treatment According to Response in Giant cEll arTeritis (TARGET) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/art.41728

PubMed Identifier: 33750043

Publication URI: http://europepmc.org/abstract/MED/33750043

Type: Journal Article/Review

Volume: 73

Parent Publication: Arthritis & rheumatology (Hoboken, N.J.)

Issue: 9

ISSN: 2326-5191